Charles Schwab Investment Management Inc. raised its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 3.1% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,151,654 shares of the medical device company's stock after buying an additional 35,035 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.58% of Cooper Companies worth $105,872,000 at the end of the most recent reporting period.
A number of other institutional investors have also modified their holdings of COO. Ashton Thomas Securities LLC purchased a new position in Cooper Companies during the 3rd quarter worth $25,000. Byrne Asset Management LLC acquired a new stake in Cooper Companies in the fourth quarter worth about $33,000. Covestor Ltd grew its stake in shares of Cooper Companies by 144.9% during the third quarter. Covestor Ltd now owns 338 shares of the medical device company's stock worth $37,000 after acquiring an additional 200 shares during the last quarter. Brown Brothers Harriman & Co. increased its holdings in shares of Cooper Companies by 191.0% during the third quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company's stock valued at $46,000 after acquiring an additional 275 shares in the last quarter. Finally, West Financial Advisors LLC purchased a new position in shares of Cooper Companies in the 4th quarter valued at approximately $49,000. 24.39% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
COO has been the topic of several research analyst reports. Citigroup dropped their target price on shares of Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. Wells Fargo & Company boosted their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a report on Friday, December 6th. Piper Sandler reissued an "overweight" rating and issued a $115.00 target price (down from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Morgan Stanley lowered their price target on Cooper Companies from $104.00 to $102.00 and set an "equal weight" rating for the company in a research report on Friday, December 6th. Finally, Robert W. Baird dropped their price target on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating on the stock in a research note on Friday, March 7th. Three analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat.com, Cooper Companies has an average rating of "Moderate Buy" and a consensus price target of $111.89.
Check Out Our Latest Report on COO
Cooper Companies Stock Performance
Shares of COO stock traded up $0.14 on Wednesday, hitting $81.17. The company had a trading volume of 204,638 shares, compared to its average volume of 1,690,366. The Cooper Companies, Inc. has a twelve month low of $78.43 and a twelve month high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The firm has a market cap of $16.20 billion, a P/E ratio of 41.68, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The company has a 50-day moving average price of $91.93 and a 200-day moving average price of $99.25.
Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.92. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. As a group, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.
About Cooper Companies
(
Free Report)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Featured Stories
Before you consider Cooper Companies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cooper Companies wasn't on the list.
While Cooper Companies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
